Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2025 Apr 14;43(1):223.
doi: 10.1007/s00345-025-05624-2.

Influence of preoperative indwelling urinary catheter on outcomes of high-power holmium laser enucleation for very large prostate (≥ 200 mL)

Matteo Tallè #  1 , Carlo Giulioni #  2 , Alessio Papaveri  1 , Francesco Mengoni  1 , Roberto Orciani  1 , Savio Domenico Pandolfo  3   4 , Ciro Imbimbo  4 , Felice Crocetto  4 , Daniele Castellani  5 , Thomas Herrmann  6 , Vineet Gauhar  7 , Angelo Cafarelli  1
Affiliations

Influence of preoperative indwelling urinary catheter on outcomes of high-power holmium laser enucleation for very large prostate (≥ 200 mL)

Matteo Tallè et al. World J Urol. .

Abstract

Purpose: to evaluate the impact of Indwelling Urinary Catheters (IUC) on perioperative and functional outcomes, as well as the safety profile, of High-Power HoLEP for the treatment of prostate gland volumes exceeding 200 cc.

Methods: A retrospective analysis was conducted on 237 patients with prostate volumes > 200 cc who underwent HoLEP between January 2016 and December 2022. Patients were included based on specific criteria, such as an International Prostate Symptom Score (IPSS) > 7 and a maximum urinary flow rate (Qmax) < 15 mL/s. Patients were categorized into two groups: Group 1 included those with IUC prior to surgery, while Group 2 comprised patients without it.

Results: A total of 237 patients with prostate volumes exceeding 200 cc underwent HoLEP, and were categorized into Group 1 (n = 63) and Group 2 (n = 174), with Group 1 exhibiting higher Charlson Comorbidity Index and BMI. Postoperative outcomes indicated a higher incidence of urinary tract infections in Group 1, as well as worse IPSS, Qmax, and PVR at 3 months; however, by the 1-year follow-up, both groups demonstrated comparable results. Longitudinal analysis revealed that both groups experienced significant functional and symptomatic improvements over time, with Group 2 showing rapid early gains that stabilized, whereas Group 1 exhibited continuous improvement from 3 months to 1 year.

Conclusion: HoLEP is an effective treatment for very large prostate volumes in patients with IUC. Although these patients are at a higher risk for UTI and initial lower Qmax, these outcomes improve by one year.

Keywords: BPH; High-power holep; Indwelling urinary catheter; Very large prostate.

PubMed Disclaimer

Conflict of interest statement

Declarations. Competing interests: The authors declare no competing interests.

Similar articles

See all similar articles

Cited by

References

    1. Ditonno F, Manfredi C, Licari LC et al (2024) Benign prostatic hyperplasia surgery: A snapshot of trends, costs, and surgical retreatment rates in the USA. Eur Urol Focus 10(5):826–832. https://doi.org/10.1016/j.euf.2024.04.006 - DOI - PubMed
    1. Zhang J, Ou Z, Zhang X et al (2020) Holmium laser enucleation of the prostate versus thulium laser enucleation of the prostate for the treatment of large-volume prostates > 80 ml: 18-month follow-up results. World J Urol 38(6):1555–1562. https://doi.org/10.1007/s00345-019-02945-x - DOI - PubMed
    1. Wiedemann A, Gedding C, Heese M, Stein J, Manseck A, Kirschner-Hermanns R, Karstedt H, Schorn A, Wagner A, Moll V, Unger U, Eisenhardt A, Bannowsky A, Linné C, Wirz S, Brammen E, Heppner HJ (2022) [Quality of life for wearers of a suprapubic or transurethral bladder catheter as lifelong permanent care]. Urologe A 61(1):18–30 German. doi:. https://doi.org/10.1007/s00120-021-01642-1 - DOI - PubMed
    1. Boxall NE, Georgiades F, Miah S, Dragos L, Armitage J, Aho TF (2021) A call for holep: AEEP for mega-prostates (≥ 200 cc). World J Urol 39(7):2347–2353. https://doi.org/10.1007/s00345-021-03708-3 - DOI - PubMed
    1. Sandhu JS, Bixler BR, Dahm P et al (2024) Management of lower urinary tract symptoms attributed to benign prostatic hyperplasia (BPH): AUA guideline amendment 2023. J Urol 211(1):11–19. https://doi.org/10.1097/JU.0000000000003698 - DOI - PubMed

LinkOut - more resources